Vietnam Nebulizer Market, By Type (Jet, Mesh, Ultrasonic), By Application (COPD, Cystic Fibrosis, Asthma, Others), By End User (Hospitals And Clinics, Emergency Centers, Home Healthcare), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

The Vietnam Nebulizer Market was valued at USD 6.22 Million in 2024 and is expected to reach USD 9.81 Million by 2030, with a CAGR of 7.85% over the forecast period. Vietnam's nebulizer market is undergoing rapid expansion, driven by a surge in respiratory health challenges and the growing adoption of inhalation therapy. The market is characterized by the presence of both global and domestic players, who are increasingly prioritizing innovation, product quality, and strategic alliances to gain a competitive edge. Companies are improving efficiency and affordability through technological advancements, aligning their offerings with the specific needs of healthcare providers and patients. This strategic focus is reshaping the competitive landscape, with manufacturers striving to deliver high-performance nebulizers that meet Vietnam’s evolving healthcare needs.

The sector's growth trajectory is reinforced by ongoing improvements in the country's healthcare infrastructure and heightened awareness of respiratory health management. Market participants are capitalizing on these trends, leveraging state-of-the-art technologies and targeted outreach to expand their market penetration and secure a stronger foothold in this rapidly maturing landscape.

Key Market Drivers

Rising Prevalence of Respiratory Diseases

The rising prevalence of respiratory diseases is a major driver of Vietnam’s nebulizer market. COPD affects ~7.1% of males aged 40+ and 1.9% of females in the same group, while asthma prevalence has increased to 4-6%, up from 2%, indicating growing recognition of respiratory health challenges. Asthma also remains significantly underdiagnosed.

Urbanization, rapid industrialization, and environmental pressures especially PM2.5 and vehicular emissions in cities like Hanoi and Ho Chi Minh City—are accelerating cases of asthma, COPD, bronchitis, and allergic rhinitis. Combined with an aging population, smoking, and occupational exposure to dust and chemicals, demand for effective treatments continues to rise, positioning nebulizers as a preferred option due to direct lung drug delivery.

Vietnam’s tropical climate and seasonal respiratory infections (including influenza and pneumonia) further exacerbate chronic conditions, increasing nebulizer use in both hospital and home-care settings. Improved diagnostics and growing awareness are driving earlier treatment, where nebulization is a key therapy. As a result, hospitals, clinics, and home healthcare providers are expanding investments in nebulizers, while manufacturers develop more user-friendly and advanced devices—supporting sustained market growth.

Expanding Healthcare Infrastructure

The expansion of Vietnam’s healthcare infrastructure is a key driver of nebulizer market growth, supported by government initiatives, private investment, and efforts to improve care accessibility. With a population exceeding 100 million, Vietnam has over 1,400 public hospitals, 350+ private hospitals, and 50,000+ clinics (Ministry of Health). Public and private providers are increasingly equipping facilities with nebulizers to address widespread respiratory diseases, while government approvals for new private hospitals in Hanoi highlight a national push to expand capacity.

Beyond urban centers, infrastructure development in rural and underserved regions through mobile medical units, rural clinics, and government-backed programs—is expanding nebulizer access to remote areas. Increased healthcare budgets, infrastructure projects, and public–private partnerships are modernizing systems, while policies promoting advanced medical devices further stimulate adoption.

Private-sector participation is intensifying competition, driving demand for high-quality, technologically advanced nebulizers. At the same time, growing home healthcare services are creating a new growth segment, with portable nebulizers supporting chronic conditions like asthma and COPD. Improved training for healthcare workers has increased awareness of nebulization therapy, leading to higher prescription and patient uptake. Modern facilities are also adopting smart nebulizers with remote connectivity and customizable settings, enhancing efficiency and accelerating market penetration.

Urbanization and Lifestyle Changes

Urbanization and lifestyle changes are major drivers of Vietnam’s nebulizer market. The urban population rose from under 20% in 1990 to over 37.55% in 2022, and cities now account for more than half of Vietnam’s GDP. Rapid industrialization, construction, and vehicular emissions especially in Hanoi and Ho Chi Minh City—have increased PM2.5 pollution, driving higher incidence of asthma, COPD, and bronchitis, and boosting demand for nebulizers.

Lifestyle shifts, including higher smoking rates, passive smoke exposure, sedentary habits, and indoor air pollution (from cooking fumes and household products), are worsening respiratory health. Occupational exposure to dust and chemicals in expanding urban industries further contributes to work-related respiratory illnesses, prompting companies to include nebulizers in workplace healthcare programs.

Urbanization also aligns with demographic aging, increasing chronic respiratory conditions and accelerating adoption of portable, easy-to-use nebulizers for continuous care. As of 2021, Vietnam had 868 urban areas: 2 special-grade, 22 grade-I, 33 grade-II, 47 grade-III, 90 grade-IV, and 674 grade-V, highlighting a rapidly expanding urban landscape.

Better healthcare access and awareness in cities are raising nebulizer adoption, while demand for home-based care is growing due to time constraints and rising costs. Compact designs support at-home management of asthma and acute infections. Fast-paced urban living, stress, weakened immunity, seasonal changes, and high pollution levels also increase respiratory infections and allergies further reinforcing sustained nebulizer usage.

Download Free Sample Report

Key Market Challenges

Limited Awareness and Education on Respiratory Health

One of the most significant challenges is the lack of awareness about respiratory health and nebulization therapy among both patients and healthcare providers, particularly in rural and underserved areas.

Many patients and even some healthcare professionals are unaware of the advantages of nebulizers over other methods, such as inhalers, for managing respiratory conditions. This knowledge gap leads to underutilization of technology. Traditional beliefs and a preference for natural or herbal remedies often discourage the adoption of medical devices like nebulizers. This limits market penetration, especially in non-urban areas. Healthcare workers, especially in smaller clinics, may lack proper training in prescribing and using nebulizers effectively. This hampers their integration into routine treatment protocols.

Addressing this challenge requires targeted awareness campaigns, educational initiatives, and training programs to improve understanding and acceptance of nebulization therapy.

High Cost of Advanced Nebulizers

The cost of purchasing and maintaining advanced nebulizers is another significant barrier to market growth.

Many patients in Vietnam, particularly those in low-income groups, find it challenging to afford high-quality nebulizers. The upfront cost of advanced devices, combined with the recurring expense of medication and maintenance, often makes them inaccessible. Healthcare insurance plans in Vietnam may not fully cover the cost of nebulizers, further discouraging adoption. This issue is particularly pronounced for patients requiring long-term treatment for chronic respiratory conditions. The market is flooded with cheaper, lower-quality nebulizers, which often fail to meet performance and durability standards. While affordable, these products can undermine trust in nebulizer efficacy and discourage future investments in better devices.

Expanding the availability of cost-effective yet reliable nebulizers and advocating for insurance coverage reforms are critical to overcoming this challenge.

Key Market Trends

Integration of Smart and Connected Nebulizer Technology

The increasing adoption of smart, connected medical devices is revolutionizing the nebulizer market, aligning with the global trend toward digital healthcare.

Smart nebulizers equipped with connectivity features such as Bluetooth and Wi-Fi enable real-time tracking of patient usage and respiratory parameters. These devices provide valuable data to healthcare providers to monitor treatment efficacy and adjust prescriptions remotely. Advanced nebulizers now include features such as reminders, usage guidance, and progress tracking via mobile apps. These innovations improve patient adherence to treatment protocols, particularly for chronic respiratory conditions. The Internet of Things (IoT) is enabling seamless integration among nebulizers, electronic health records (EHRs), and telehealth platforms. This connectivity enhances the overall treatment ecosystem, making nebulizers a vital component of modern respiratory care.

The shift toward smart nebulizers will drive demand for technologically advanced solutions, encouraging innovation and enabling manufacturers to differentiate their offerings.

Growing Preference for Portable and User-Friendly Devices

Consumer demand for convenience is reshaping the nebulizer market, with a growing preference for portable and easy-to-use devices.

Modern lifestyles and the increasing prevalence of respiratory conditions among working professionals and travelers have fueled demand for compact and lightweight nebulizers. These devices help patients maintain mobility and flexibility in managing their conditions. Portable nebulizers equipped with rechargeable batteries are gaining popularity because they eliminate the need for electrical outlets, making them suitable for both urban and rural users. User-friendly interfaces and ergonomic designs have made nebulizers more accessible, even for elderly patients and children. These features reduce the learning curve and encourage widespread adoption.

The growing focus on portability and user-centric design will drive product diversification, allowing manufacturers to target niche markets and expand their consumer base.

Segmental Insights

Type Insights

Based on the category of Type, the Jet Nebulizer segment emerged as the dominant in the Vietnam Nebulizer Market in 2024. Jet nebulizers are highly effective in delivering medication directly to the respiratory tract, making them a preferred choice for treating various conditions such as asthma, COPD, bronchitis, and acute respiratory infections. Jet nebulizers are compatible with a variety of medications, including bronchodilators, corticosteroids, and antibiotics, enabling them to address a wide spectrum of respiratory conditions. Their ability to deliver particles of different sizes ensures a tailored treatment for both upper and lower respiratory tract ailments, enhancing their utility across diverse patient profiles.

Affordability is a critical factor driving the dominance of jet nebulizers in Vietnam, particularly in a market where price sensitivity influences purchasing decisions. Compared to ultrasonic and mesh nebulizers, jet nebulizers are generally more economical, making them accessible to a broader population, including those in lower-income brackets. While mesh nebulizers require frequent cleaning and replacement of delicate components, jet nebulizers are durable and relatively easy to maintain, reducing long-term ownership costs. Jet nebulizers have long been the standard choice in hospitals, clinics, and healthcare centers across Vietnam, contributing to their widespread acceptance. Healthcare providers are well-versed in prescribing and using jet nebulizers, which facilitates their integration into treatment protocols. Public and private healthcare institutions prefer jet nebulizers for their reliability and ability to handle continuous usage, making them a staple in respiratory care settings. These factors are expected to drive the growth of this segment.

Download Free Sample Report

Regional Insights

Southern Vietnam emerged as the dominant in the Vietnam Nebulizer market in 2024, holding the largest market share in terms of value. The southern region, particularly HCMC, is Vietnam's economic and financial hub. It contributes significantly to the country’s GDP and exhibits higher levels of urbanization and industrial activity. The region’s economic growth has translated into higher disposable incomes, which enables greater access to healthcare products, including nebulizers. A large portion of the population in this region has the financial means to invest in healthcare devices. This is crucial because nebulizers can be costly, and greater economic prosperity in southern Vietnam allows consumers to prioritize health and purchase advanced respiratory care products. The growing affluence has also led to increased private healthcare spending, further driving demand for nebulizers in hospitals, clinics, and at home. Consumers are more willing to invest in high-quality, reliable medical devices for managing chronic respiratory conditions.

The southern region is home to the most advanced healthcare facilities in Vietnam, particularly in HCMC, which boasts a large number of modern hospitals, clinics, and specialty care centers. Hospitals and healthcare providers in this region are more likely to adopt and use technologically advanced medical equipment, including nebulizers. The presence of leading medical institutions and respiratory care specialists in HCMC ensures that nebulizers are more frequently prescribed and utilized. In addition to public healthcare facilities, the private healthcare sector in the southern region is flourishing, offering high-end services, including nebulizer treatments. Private hospitals and clinics often attract patients from across the country for their high-quality care and access to advanced medical devices.

Recent Development

• In August 2025, Long Châu pharmacy chain and OMRON Healthcare announced an expanded strategic collaboration in Vietnam to roll out a broader at-home health monitoring and care device ecosystem.
• In August 2025, Long Châu stated it was distributing OMRON nebulizers (máy xông khí dung OMRON) in Vietnam as part of its home-care device portfolio to support respiratory care for conditions such as asthma and bronchitis, with specific usefulness noted for children and older adults.
• In July 2024, CHIDO introduced a new version of its handheld nebulizer (CNB69026) in Vietnam and positioned it for both household and medical-unit use cases.

Key Market Players

• Nareena Lifesciences Private Limited
• Omron Healthcare Manufacturing Vietnam Co. Ltd
• PARI GmbH
• Philip Morris International (PMI)
• DMED Medical Equipment Company, LTD

Report Scope:

In this report, the Vietnam Nebulizer Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Vietnam Nebulizer Market, By Type:

o   Jet

o   Mesh

o   Ultrasonic

• Vietnam Nebulizer Market, By Application:

o   COPD

o   Cystic Fibrosis

o   Asthma

o   Others

• Vietnam Nebulizer Market, By End User:

o   Hospitals And Clinics

o   Emergency Centers

o   Home Healthcare

• Vietnam Nebulizer Market, By Region:

o   Northern Vietnam

o   Central Vietnam

o   Southern Vietnam

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Vietnam Nebulizer Market.

Available Customizations:

 Vietnam Nebulizer market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).